In this Q&A, Dr Sanghavi shares reflections on the mentors who inspired her, the personal challenges she has overcome and her hopes for a future in which sex-based differences in cardiovascular disease are better understood and acted upon.
June was a dynamic month in cardiovascular medicine, marked by notable regulatory approvals and clinical trial progress across several therapeutic areas. Advances in hypertension management, lipid lowering and cardiometabolic care continue to shape the treatment landscape, while evolving data in pulmonary arterial hypertension underscore the importance of ongoing innovation. This month’s roundup highlights the latest developments poised to impact clinical practice and patient outcomes.
This August, Boston will host one of the most influential gatherings in cardiovascular medicine as the American Society for Preventive Cardiology (ASPC) convenes its 2025 Congress on Cardiovascular Disease Prevention. Set for 1–3 August 2025 at the Omni Boston Hotel at the Seaport, Boston, MA, USA, the meeting will bring together global experts, showcase cutting-edge research, and feature more than 200 abstract posters.
Cardiovascular medicine stands at a pivotal crossroads—shaped by rapid advances in precision therapies, a deepening understanding of disease mechanisms, and an urgent imperative to address global health disparities. As the burden of cardiovascular disease continues to evolve, so too ...
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
Early-career cardiologists and researchers face a complex landscape: they must navigate the increasing clinical complexity of cardiovascular disease, stay abreast of rapid scientific developments and manage the pressures of clinical, academic and personal responsibilities. Recognising the need for greater support, ...
Acute coronary syndromes (ACS) take center stage in this timely interview with Professor Sunil Rao of NYU Grossman School of Medicine and NYU Langone Health System, New York, NY, USA, as he delves into the driving forces behind the much-anticipated 2025 updates to the ACS management guidelines presented at ACC.25, Chicago, IL, USA, 29–31 March 2025.
At #ACVC2025 in Florence, a study on out-of-hospital cardiac arrest (OHCA) highlighted the importance of early cardiopulmonary resuscitation (CPR). Researchers found that rapid CPR initiation, rather than the type of rescuer, significantly impacts survival outcomes. Delays in return of spontaneous circulation (ROSC) led to higher mortality risks.
Welcome to this issue of Heart International. As ever, we aim to provide our readers with the latest developments, insights, and evidence-based discussions in cardiovascular care. This edition is particularly poignant, as we begin with a heartfelt tribute to an ...
Revascularization for patients with ischaemic left ventricular (LV) systolic dysfunction takes one of two forms - percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG), both of which have positives and negatives. STICH, published in 2011, analysed the role of CABG in patients with LV systolic dysfunction and looked at improvement of clinical outcomes in 1,212 patients from 22 countries across the world, optimised to either optimal medical therapy or optimal medical therapy plus CABG. REVIVED-BCIS2 in 2022 looked at 700 patients in the UK with a similar patient population of 35% ejection fraction or less, randomized to PCI or optimal medical therapy. This interview dives into their analysis of the results from these exciting trials and investigation into the discrepancies between the outcomes.
touchCARDIO spoke with Dr Mike Gibson, Harvard Medical School, Boston, MA, USA to discuss the results of his trial investigating the relationship between apolipoprotein A-I infusions and cardiovascular outcomes, presented at ESC 2024. He explains that while high-density lipoprotein (HDL) is generally associated with good outcomes, not all HDL is equally effective at removing cholesterol from plaque, a process known as cholesterol efflux, which is crucial for better outcomes after a heart attack.
The Ground-BrEAking Electroporation-based inTervention for Atrial Fibrillation (BEAT-AF) treatment project is an initiative funded by the European Commission from the European Union's Horizon 2020 research and innovation programme, and managed under the European Health and Digital Executive Agency (grant number 945125).1,2Â The ...
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.